Molecular implications of RET mutations for pheochromocytoma risk in multiple endocrine neoplasia 2.

T. S GUJRAL , L. M MULLIGAN
Annals of the New York Academy of Sciences 1073 ( 1) 234 -240

9
2006
Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours

Charis Eng , Darrin P. SmIth , Lois M. MullIgan , Maria A. Nagal
Human Molecular Genetics 3 ( 2) 237 -241

455
1994
A TaqI RFLP in Xq26-Xqter detected by pX45h [HGM8 no. DXS100h].

K. Wrogemann , B. Arveiler , I. Oberle , L.M. Milligan
Nucleic Acids Research 14 ( 13) 5572 -5572

3
1986
A novel polymorphism in the coding sequence of the human RET proto-oncogene

Patrick Edery , Tania Atti� , LoisM. Mulligan , Anna Pelet
Human Genetics 94 ( 5) 579 -580

14
1994
Des mutations du proto-oncogène RET dans la maladie de Hirschusprung

S LYONNET , R EDERY , LM MULLIGAN , A PELET
Comptes rendus de l'Académie des sciences. Série 3, Sciences de la vie 317 ( 4) 358 -362

1994
Endocrine cancers

HARRIET FEILOTTER , LOIS MULLIGAN
Inherited Susceptibility to Cancer: Clinical, Predictive and Ethical Perspectives 326 -326

1
1998
24. FROM GENES TO DECISIONS

LOIS M MULLIGAN
Steven T. Rosen, MD, Series Editor 417 -417

2006
Heterogeneous Mutation of the RET Proto-oncogene in Subpopulations of Medullary Thyroid Carcinoma

Bruce A. J. Ponder , Friedhelm Raue , Catherine S. Healey , Lois M. Mulligan
Cancer Research 56 ( 9) 2167 -2170

151
1996
The RET signaling pathway: Linking developmental and neoplastic roles

Lois M. Mulligan
Cancer Research 65 1474 -1475

2005
Mutation analysis of glial cell line-derived neurotrophic factor (GDNF), a ligand for the RET/GDNF receptor α complex, in sporadic phaeochromocytomas

Eamonn R. Maher , Lois M. Mulligan , Sergio P. A. Toledo , Charis Eng
Cancer Research 57 ( 2) 310 -313

26
1997
Investigation of germline GFRα-1 mutations in Hirschsprung disease

Antje Goessling , Antje Goessling , Andreas Von Deimling , Anna Pelet
Journal of Medical Genetics 36 ( 3) 217 -220

36
1999
Germline and Somatic Mutations in an Oncogene: RET Mutations in Inherited Medullary Thyroid Carcinoma

Diana L. Learoyd , Diana L. Learoyd , Bruce A.J. Ponder , Amanda G. Capes
Cancer Research 56 ( 6) 1241 -1243

53
1996
Clinical value of direct DNA analysis of the RET proto-oncogene in families with multiple endocrine neoplasia type 2A.

Bruce A J Ponder , Lois M. Mulligan , Charles E. Jackson , Gerald L. Feldman
Surgery 116 ( 6) 1042 -1047

12
1994
Characterization of RET proto-oncogene 3' splicing variants and polyadenylation sites: a novel C-terminus for RET.

Bruce A J Ponder , Lois M. Mulligan , Charis Eng , Charis Eng
Oncogene 11 ( 10) 2039 -2045

143
1995
A 9.75-Mb Map across the Centromere of Human Chromosome 10

Michael S. Jackson , Chee Gee See , Lois M. Mulligan , Brenda F. Lauffart
Genomics 33 ( 2) 258 -270

36
1996
Genotype-phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium.

Lois M. Mulligan , D. J. MARSH , B. G. ROBINSON , I. SCHUFFENECKER
Journal of Internal Medicine 238 ( 4) 343 -346

244
1995
Transcriptional repression of the RET proto-oncogene by a mitogen activated protein kinase-dependent signalling pathway.

Scott D. Andrew , Amanda Capes-Davis , Patric J.D. Delhanty , Deborah J. Marsh
Gene 298 ( 1) 9 -19

15
2002
High penetrance of pheochromocytoma associated with the novel C634Y/Y791F double germline mutation in the RET protooncogene

Rodrigo A Toledo , Simona M Wagner , Flavia L Coutinho , Delmar M Lourenço Jr
The Journal of Clinical Endocrinology and Metabolism 95 ( 3) 1318 -1327

39
2010